All I know is that the trial will be a Phase 2. I saw Entyvio's (vedolizumab) commercial for ulcerative colitis and Crohn's disease last night. It took Entyvio about one year to complete its P2 trial. I expect B-UP to be quicker since it's a topical treatment.